We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Monthly Production Capacity: 20tons
Packaging Information: 25kg/drum
Delivery Lead Time: 5-7 days
Sample Provided: yes
Payment Terms: T/T
Iron is an important raw material for producing hemoglobin in the human body, and the demand for iron during pregnancy will be higher. Iron deficiency anemia is currently the most common type of nutritional deficiency, which is prone to occur during pregnancy. Ferroglycine is a drug used to treat iron deficiency anemia. Ferroglycine is a light yellow brown green crystalline powder with a long shelf life and is not easily spoiled.
Glycine ferrous does not have the iron odor of other iron agents, and is odorless and soluble organic iron. The production method of ferrous glycine is mainly obtained by reacting glycine with reducing iron. The main physiological function of ferrous glycine is to prevent and improve iron deficiency anemia. The absorption rate of ferrous glycine is very high, and it can also promote the absorption of elements such as calcium, zinc, selenium, etc. Adding it to food will not cause food odor. Iron deficiency has become a common disease, especially iron deficiency poverty, which is more common in pregnant women and children.
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
![2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethanamine hydrochloride (1:1)1053239-39-6](https://eimg.pharmasources.com/img_Cphi_en/Product/2019_02/Mimg_1902201003682994.jpg!145)
